Urolithin A
Also known as: 3,8-dihydroxyurolithin
Classification
Supplement
Regulatory Status
n/a
Sources
2
Review
n/a
Overview
Urolithin A is a gut microbiota-derived metabolite of ellagitannins studied for effects on mitochondrial function and muscle-related biomarkers; mechanism details in humans remain an active research area.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
mitochondrial quality-related signaling (investigational)
Benefits
A randomized clinical trial studied urolithin A on muscle endurance and mitochondrial-health biomarkers in older adults; broader anti-aging or lifespan claims are not established.
Interactions & cautions
Drug interactions
no specific drug interaction established in authoritative labeling — Unknown interaction potential with concurrent drugs (review)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw